Pharmaceutical Risk Based Clinical Quality Assurance Conference

February 4-5, 2020 | San Diego, CA

Pharmaceutical Risk Based Clinical Quality Assurance Conference
February 4-5, 2020 | San Diego, CA

Download Overview

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

“I thought the conference was excellent!  Having a conference tailored to one discipline made each panel and contact relevant.”

Director, Compliance & Legal Affairs
Orexigen

“Great insight to hear payer perspective in contracting and account management and the changing healthcare landscape.”

Channel Liaison
Biogen

“It was definitely an excellent well-rounded opportunity to meet new people, get new ideas, and get an in-depth education on what’s to come with the FDA collaborations.”

Quality Engineer
Centurion Medical Products

“It was very well organized event and high quality, the fact to have an IVD track was also interesting. Thanks, I will recommend the Q1 event!”

Regulatory Affairs – EMEA Regional Head
BIOMERIEUX

“The organization and support staff were fantastic! I’m looking forward to next year.”

Global Business Project Lead
Genentech

About the Conference:

The Pharmaceutical Risk Based Clinical Quality Assurance Conference will address the concerns surrounding the implementation of risk monitoring by bringing together clinical quality assurance professionals, regulatory authorities and risk management experts to examine approaches for a successful clinical. Sessions will be presented by clinical quality assurance experts who have successfully built strategies for thorough CRO oversight, comprehensive documentation protocols, and the development of standardized models for risk assessment. Through concrete case study examples and open panel discussions between industry leaders, this program will support clinical quality teams that prioritize clinical trial success and align methodologies with the latest guidance from regulatory authorities.

Core Topics to be Addressed:

  • Utilizing audit findings to compliment risk monitoring approaches
  • Standardizing risk monitoring models for various clinical studies
  • Implementation of data driven risk assessment models
  • Anticipating CRO consolidation and strategies for retraining staff
  • Utilizing available resources for risk monitoring strategy development
  • Integration of risk monitoring through established clinical processes

Program Highlights:

  • Diverse industry and regulatory perspectives
  • Interactive discussions to foster collaborative exchange
  • Focus on practical, real-world solutions to pre-launch
  • Collaborative sessions focused on hands-on learning

Core Topics to be Addressed:

  • Utilizing audit findings to compliment risk monitoring approaches
  • Standardizing risk monitoring models for various clinical studies
  • Implementation of data driven risk assessment models
  • Anticipating CRO consolidation and strategies for retraining staff
  • Utilizing available resources for risk monitoring strategy development
  • Integration of risk monitoring through established clinical processes

Download Overview

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Audience

75 Attendees

All attendees come directly from pharmaceutical and biotech companies

Distinguished Presenters

Speaker recruitment in progress

Networking

Networking time is built into the agenda to allow industry peers to connect and exchange ideas

Open Dialogue and Group Share

Each presentation is followed by 10-15 minutes of open dialogue for questions and exchange of best practices

Share This